MLYS
NASDAQStockMineralys Therapeutics, Inc.
$26.52-0.47 (-1.74%)
52-Week Range
$11.77
$47.33
Key Stats
Market Cap
1.8B
P/E Ratio
—
Dividend Yield
—
Beta
0.57
Volume
883.8K
Avg Volume
1.2M
Performance
1M
-2.21%
3M
-25.07%
6M
-27.87%
YTD
-24.42%
1Y
+89.80%
3Y
+75.49%
5Y
+46.37%
Price Chart
ETF Exposure
MLYS is held by 101 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| WSML | iShares MSCI World Small-Cap ETF | 0.01% |
| WSML.L | iShares MSCI World Small Cap UCITS ETF | 0.01% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.01% |
| WDSC.L | State Street SPDR MSCI World Small Cap UCITS ETF (Acc) | 0.01% |
| WOSC.L | State Street SPDR MSCI World Small Cap UCITS ETF (Acc) | 0.01% |
| ZPRS.DE | State Street SPDR MSCI World Small Cap UCITS ETF (Acc) | 0.01% |
| DFAS | Dimensional - US Small Cap ETF | 0.01% |
| SMMD | iShares Russell 2500 ETF | 0.01% |
| DXUV | Dimensional - US Vector Equity ETF | 0.01% |
| HDG | ProShares - Hedge Replication ETF | 0.01% |
| ONEQ | FIDELITY NASDAQ COMPOSITE INDEX ETF | 0.01% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| USFM.L | UBS MSCI USA Select Factor Mix UCITS ETF USD dis | 0.00% |
| ZPRV.DE | State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETF | 0.00% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.00% |
| DFUS | Dimensional - US Equity Market ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| VUN.TO | Vanguard U.S. Total Market Index ETF | 0.00% |
| VUS.TO | Vanguard U.S. Total Market Index ETF (CAD-hedged) | 0.00% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.00% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.00% |
| DFSU | Dimensional - US Sustainability Core 1 ETF | 0.00% |
| EAOA | iShares ESG Aware 80/20 Aggressive Allocation ETF | 0.00% |
| EAOM | iShares ESG Aware 40/60 Moderate Allocation ETF | 0.00% |
| EAOR | iShares ESG Aware 60/40 Balanced Allocation ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| VEQT.TO | Vanguard All-Equity ETF Portfolio | 0.00% |
| XEQT.TO | iShares Core Equity ETF Portfolio | 0.00% |
| XUU.TO | iShares Core S&P U.S. Total Market Index ETF | 0.00% |
| AVTM | Avantis Total Equity Markets ETF 1 | 0.00% |
| AVUS | Avantis U.S. Equity ETF | 0.00% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| EAOK | iShares ESG Aware 30/70 Conservative Allocation ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| LSLT | Pacer Salt Low truBeta US Market ETF | 0.00% |
| SLT | Pacer Salt High truBeta US Market ETF | 0.00% |
| TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 0.00% |
| VCNS.TO | Vanguard Conservative ETF Portfolio | 0.00% |
| VETS | Pacer Military Times Best Employers ETF | 0.00% |
| VIRS | Pacer BioThreat Strategy ETF | 0.00% |
About MLYS ETF Exposure
Mineralys Therapeutics, Inc. (MLYS) is held by 101 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.8B, MLYS is a widely held institutional stock. The stock currently trades at $26.52. Investors can gain exposure to MLYS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold MLYS, sorted by portfolio weight.